Annual CFO
-$69.53 M
+$6.98 M+9.12%
December 31, 2023
Summary
- As of February 8, 2025, BOLT annual cash flow from operations is -$69.53 million, with the most recent change of +$6.98 million (+9.12%) on December 31, 2023.
- During the last 3 years, BOLT annual CFO has fallen by -$22.22 million (-46.96%).
- BOLT annual CFO is now -604.26% below its all-time high of -$9.87 million, reached on December 31, 2018.
Performance
BOLT Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$13.97 M
+$2.18 M+13.48%
September 30, 2024
Summary
- As of February 8, 2025, BOLT quarterly cash flow from operations is -$13.97 million, with the most recent change of +$2.18 million (+13.48%) on September 30, 2024.
- Over the past year, BOLT quarterly CFO has increased by +$2.18 million (+13.48%).
- BOLT quarterly CFO is now -250.38% below its all-time high of -$3.99 million, reached on June 30, 2021.
Performance
BOLT Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$61.12 M
+$2.78 M+4.35%
September 30, 2024
Summary
- As of February 8, 2025, BOLT TTM cash flow from operations is -$61.12 million, with the most recent change of +$2.78 million (+4.35%) on September 30, 2024.
- Over the past year, BOLT TTM CFO has increased by +$2.78 million (+4.35%).
- BOLT TTM CFO is now -534.20% below its all-time high of -$9.64 million, reached on March 31, 2020.
Performance
BOLT TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
BOLT Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +9.1% | +13.5% | +4.3% |
| 3 y3 years | -47.0% | +13.5% | +4.3% |
| 5 y5 years | -604.3% | +13.5% | +4.3% |
BOLT Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -21.8% | +9.1% | -3.8% | +42.6% | -7.1% | +25.1% |
| 5 y | 5-year | -163.9% | +9.1% | -250.4% | +42.6% | -534.2% | +25.1% |
| alltime | all time | -604.3% | +9.1% | -250.4% | +42.6% | -534.2% | +25.1% |
Bolt Biotherapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$13.97 M(-13.5%) | -$61.12 M(-4.4%) |
| Jun 2024 | - | -$16.14 M(-3.6%) | -$63.91 M(+1.6%) |
| Mar 2024 | - | -$16.75 M(+17.4%) | -$62.88 M(-9.6%) |
| Dec 2023 | -$69.53 M(-9.1%) | -$14.27 M(-14.8%) | -$69.53 M(-5.0%) |
| Sep 2023 | - | -$16.75 M(+10.8%) | -$73.21 M(+4.7%) |
| Jun 2023 | - | -$15.11 M(-35.4%) | -$69.91 M(-7.5%) |
| Mar 2023 | - | -$23.40 M(+30.3%) | -$75.59 M(-1.2%) |
| Dec 2022 | -$76.50 M | -$17.95 M(+33.5%) | -$76.50 M(+0.2%) |
| Sep 2022 | - | -$13.45 M(-35.3%) | -$76.35 M(-6.5%) |
| Jun 2022 | - | -$20.79 M(-14.5%) | -$81.62 M(+25.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$24.31 M(+36.6%) | -$64.82 M(+13.6%) |
| Dec 2021 | -$57.07 M(+20.6%) | -$17.79 M(-5.0%) | -$57.07 M(+9.4%) |
| Sep 2021 | - | -$18.73 M(+369.8%) | -$52.16 M(+13.5%) |
| Jun 2021 | - | -$3.99 M(-75.9%) | -$45.95 M(-15.3%) |
| Mar 2021 | - | -$16.56 M(+28.5%) | -$54.23 M(+14.6%) |
| Dec 2020 | -$47.31 M(+79.6%) | -$12.89 M(+3.0%) | -$47.31 M(+37.5%) |
| Sep 2020 | - | -$12.52 M(+2.0%) | -$34.42 M(+57.1%) |
| Jun 2020 | - | -$12.27 M(+27.3%) | -$21.90 M(+127.3%) |
| Mar 2020 | - | -$9.64 M | -$9.64 M |
| Dec 2019 | -$26.34 M(+166.8%) | - | - |
| Dec 2018 | -$9.87 M | - | - |
FAQ
- What is Bolt Biotherapeutics annual cash flow from operations?
- What is the all time high annual CFO for Bolt Biotherapeutics?
- What is Bolt Biotherapeutics annual CFO year-on-year change?
- What is Bolt Biotherapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Bolt Biotherapeutics?
- What is Bolt Biotherapeutics quarterly CFO year-on-year change?
- What is Bolt Biotherapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Bolt Biotherapeutics?
- What is Bolt Biotherapeutics TTM CFO year-on-year change?
What is Bolt Biotherapeutics annual cash flow from operations?
The current annual CFO of BOLT is -$69.53 M
What is the all time high annual CFO for Bolt Biotherapeutics?
Bolt Biotherapeutics all-time high annual cash flow from operations is -$9.87 M
What is Bolt Biotherapeutics annual CFO year-on-year change?
Over the past year, BOLT annual cash flow from operations has changed by +$6.98 M (+9.12%)
What is Bolt Biotherapeutics quarterly cash flow from operations?
The current quarterly CFO of BOLT is -$13.97 M
What is the all time high quarterly CFO for Bolt Biotherapeutics?
Bolt Biotherapeutics all-time high quarterly cash flow from operations is -$3.99 M
What is Bolt Biotherapeutics quarterly CFO year-on-year change?
Over the past year, BOLT quarterly cash flow from operations has changed by +$2.18 M (+13.48%)
What is Bolt Biotherapeutics TTM cash flow from operations?
The current TTM CFO of BOLT is -$61.12 M
What is the all time high TTM CFO for Bolt Biotherapeutics?
Bolt Biotherapeutics all-time high TTM cash flow from operations is -$9.64 M
What is Bolt Biotherapeutics TTM CFO year-on-year change?
Over the past year, BOLT TTM cash flow from operations has changed by +$2.78 M (+4.35%)